Cargando…
Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight
BACKGROUND: Methylation patterns in circulating cell-free DNA are potential biomarkers for cancer and other pathologies. Currently, bisulfite treatment underpins most DNA methylation analysis methods, however, it is known to fragment DNA. Circulating DNA is already short, and further fragmentation d...
Autores principales: | Werner, Bonnita, Yuwono, Nicole Laurencia, Henry, Claire, Gunther, Kate, Rapkins, Robert William, Ford, Caroline Elizabeth, Warton, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814277/ https://www.ncbi.nlm.nih.gov/pubmed/31652288 http://dx.doi.org/10.1371/journal.pone.0224338 |
Ejemplares similares
-
The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021) -
Total and endothelial cell-derived cell-free DNA in blood plasma does not change during menstruation
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021) -
Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
por: Werner, Bonnita, et al.
Publicado: (2022) -
The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020) -
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
por: Warton, Kristina, et al.
Publicado: (2016)